Literature DB >> 18376387

Classic Kaposi Sarcoma in the United States over the last two decades: a clinicopathologic and molecular study of 438 non-HIV-related Kaposi Sarcoma patients with comparison to HIV-related Kaposi Sarcoma.

Kim M Hiatt1, Ann M Nelson, Jack H Lichy, Julie C Fanburg-Smith.   

Abstract

Classic Kaposi sarcoma is rare and occurs predominantly in Mediterranean and Middle Eastern men. Since the emergence of acquired immune deficiency syndrome (AIDS)-related Kaposi sarcoma, the incidence, clinicopathologic features, and molecular human herpesvirus 8 (HHV-8) association of American Classic Kaposi Sarcoma has not been fully explored. This study compares Classic Kaposi Sarcoma to AIDS-related Kaposi Sarcoma over the same two decade time period. There were 438 histologically and clinically confirmed Classic Kaposi Sarcoma patients. The ethnic/racial distribution included Caucasian/American (56%), Mediterranean (22%), South American Hispanic (18%), Black (10%), western European (4%), Middle East (4%), Scandinavian (2%), and other (2%). Classic Kaposi Sarcoma was more common in men, 7:1, with a mean age of 74 years. The lesions presented in the lower extremity (69%), in the nodular stage (83%), and HHV-8 was detected by PCR in 40/41 randomly selected cases. A second, non-Classic Kaposi Sarcoma, malignancy was present in 42% (n=45) of the 108 Classic Kaposi Sarcoma patients with complete clinical information, 73% (33 patients) with a higher incidence over the general population. Follow-up of <1-19 years (mean=4.8 years) revealed that 24% of patients died of second malignancy, 22% died of other medical conditions, 2% died of treatment-related complications, and 2% patients died of widespread disease. Thirty-five percent are alive with no evidence of disease and 15% with persistent disease. Human immunodeficiency virus-related Kaposi Sarcoma was observed in 354 cases. There was a male predominance and more aggressive behavior, with higher rates of visceral and disseminated disease. While Classic Kaposi Sarcoma in the United States is an indolent disease and rarely accounts for patient demise, predominantly affecting Caucasian/American males on the lower extremity in the nodular phase, it more importantly may denote an underlying other malignancy. Current PCR probes detect HHV-8 in 98% of Classic Kaposi Sarcoma cases. In comparison, AIDS-related Kaposi Sarcoma is predominately multicentric, visceral, and disseminated, with more aggressive behavior.

Entities:  

Mesh:

Year:  2008        PMID: 18376387     DOI: 10.1038/modpathol.2008.15

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  16 in total

1.  Ultraviolet Radiation and Kaposi Sarcoma Incidence in a Nationwide US Cohort of HIV-Infected Men.

Authors:  Elizabeth K Cahoon; Eric A Engels; D Michal Freedman; Mary Norval; Ruth M Pfeiffer
Journal:  J Natl Cancer Inst       Date:  2016-12-31       Impact factor: 13.506

2.  Skin Cancer in People of Color: A Systematic Review.

Authors:  George A Zakhem; Akshay N Pulavarty; Jenna C Lester; Mary L Stevenson
Journal:  Am J Clin Dermatol       Date:  2021-12-13       Impact factor: 7.403

3.  LANA-1, Bcl-2, Mcl-1 and HIF-1alpha protein expression in HIV-associated Kaposi sarcoma.

Authors:  E Long; M Ilie; V Hofman; K Havet; E Selva; C Butori; J P Lacour; A M Nelson; G Cathomas; P Hofman
Journal:  Virchows Arch       Date:  2009-05-30       Impact factor: 4.064

Review 4.  Lymphatic Function and Dysfunction in the Context of Sex Differences.

Authors:  Claire E Trincot; Kathleen M Caron
Journal:  ACS Pharmacol Transl Sci       Date:  2019-09-09

5.  Pulmonary involvement in acquired immunodeficiency syndrome-associated Kaposi's sarcoma: a descriptive analysis of thin-section manifestations in 29 patients.

Authors:  Chunshuang Guan; Yuxin Shi; Jinxin Liu; Yuxin Yang; Qianqian Zhang; Zhiyan Lu; Guangping Zheng; Wen Ye; Ming Xue; Xingang Zhou; Na Zhang; Hongjun Li; Ruming Xie; Budong Chen; Puxuan Lu
Journal:  Quant Imaging Med Surg       Date:  2021-02

6.  Classic Kaposi's sarcoma in Morocco: clinico-epidemiological study at the National Institute of Oncology.

Authors:  Hassan Errihani; Narjisse Berrada; Soundouss Raissouni; Fadoi Rais; Hind Mrabti; Ghizlane Rais
Journal:  BMC Dermatol       Date:  2011-11-11

7.  Incidence of AIDS-Related Kaposi Sarcoma in All 50 United States From 2000 to 2014.

Authors:  Donna L White; Abiodun Oluyomi; Kathryn Royse; Yongquan Dong; Harrison Nguyen; Elaine Chang; Peter Richardson; Li Jiao; Jose M Garcia; Jennifer R Kramer; Aaron P Thrift; Elizabeth Chiao
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-01       Impact factor: 3.771

8.  Incidence of Kaposi Sarcoma in Sweden is Decreasing.

Authors:  Giedre Bieliauskiene; Oscar Zaar; Isabel Kolmodin; Martin Gillstedt; John Paoli
Journal:  Acta Derm Venereol       Date:  2020-10-28       Impact factor: 3.875

9.  Prevalence of human cytomegalovirus, polyomaviruses, and oncogenic viruses in glioblastoma among Japanese subjects.

Authors:  Yumiko Hashida; Ayuko Taniguchi; Toshio Yawata; Sena Hosokawa; Masanao Murakami; Makoto Hiroi; Tetsuya Ueba; Masanori Daibata
Journal:  Infect Agent Cancer       Date:  2015-01-27       Impact factor: 2.965

10.  Cause-specific mortality in classic Kaposi's sarcoma: a population-based study in Italy (1995-2002).

Authors:  V Ascoli; G Minelli; M Kanieff; R Crialesi; L Frova; S Conti
Journal:  Br J Cancer       Date:  2009-08-25       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.